期刊文献+

细胞增殖信号传递抑制剂在心脏移植中的应用进展(续)

原文传递
导出
摘要 Bestetti等研究显示,对于移植术后因钙调磷酸酶抑制剂(CNI)引起的肾功能不全患者,以细胞增殖信号传递抑制剂(PSI)类药物替代CNI,血清肌酐水平显著降低,肾功能明显改善,而急性排斥反应的发病率并不增加。更有甚者,对于移植术后需进行血液透析的患者,改用PSI类药物后,肾功能也可以得到部分改善,甚至可以免于血液透析.
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2007年第12期767-767,共1页 Chinese Journal of Organ Transplantation
  • 相关文献

参考文献7

  • 1Bestetti R, Theodoropoulos TA, Burdmann EA, et al. Switch from calcineurin inhibitors to sirolimus-induced renal recovery in heart transplant recipients in the midterm follow-up. Transplantation,2006,81(5) :692-696.
  • 2Gleissner CA, Doeseh A, Ehlermann P, et al. Cyelosporine withdrawal improves renal function in heart transplant patients on reduced- dose cyclosporine therapy. Am J Transplant, 2006,6(11) : 2750-2758.
  • 3Panwalkar A, Verstovsek S, Giles FJ. Mammalian target of rapamyein inhibition as therapy for hematologic malignancies. Cancer,2004, 100(4) :657-666.
  • 4Kauffman HM, Cherikh WS, Cheng Y, et al. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation,2005,80(7) :883-889.
  • 5Wasywieh CA, Croxson MC, van Doomum GJ, et al. Sirolimus for Kaposi's sarcoma. J Heart Lung Transplant,2006,25(6) :726-729.
  • 6Pham PT,Pham PC,Danovitch GM,et al. Sirolimus-associated pulmonary toxicity. Transplantation,2004,77(8):1215-1220.
  • 7Lindenfeld JA, Simon SF, Zamora MR, et al. BOOP is common in cardiac transplant recipients switched from a calcineurin inhibitor to sirolimus. Am J Transplant,2005, 5(6) : 1392-1396.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部